Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Verona Pharma PLC increased its cash reserves by 19.29%, or 43.95m. Cash Flow from Financing totalled 92.87m or -- of revenues. In addition the company used 50.22m for operations while cash from investing was breakeven.
Cash flow per share | -1.55 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.08 |
---|---|
Tangible book value per share | 2.07 |
More ▼
Balance sheet in USDView more
Current ratio | 8.61 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.7113 |
---|---|
Total debt/total capital | 0.4156 |
More ▼